{"id":"https://openalex.org/W7224202033","doi":"https://doi.org/10.3390/ph19111707","title":"Enabling Irreversible FAP Inhibitors for Routine Clinical Use: Process and Quality Control Validation for [68Ga]Ga-FAPi-mFS and [177Lu]Lu-FAPi-mFS","display_name":"Enabling Irreversible FAP Inhibitors for Routine Clinical Use: Process and Quality Control Validation for [68Ga]Ga-FAPi-mFS and [177Lu]Lu-FAPi-mFS","publication_year":2026,"publication_date":"2026-10-29","ids":{"openalex":"https://openalex.org/W7224202033","doi":"https://doi.org/10.3390/ph19111707"},"language":"en","primary_location":{"id":"doi:10.3390/ph19111707","doi":"https://doi.org/10.3390/ph19111707","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ph19111707","pdf_url":null,"source":{"id":"https://openalex.org/S16322639","display_name":"Pharmaceuticals","issn_l":"1424-8247","issn":["1424-8247"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3390/ph19111707","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044765728","display_name":"Sarah Stephan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Sarah Stephan","raw_affiliation_strings":["Curanosticum MVZ GmbH Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, 65191 Wiesbaden, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Curanosticum MVZ GmbH Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, 65191 Wiesbaden, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101922799","display_name":"Subhadeep Paul","orcid":"https://orcid.org/0009-0006-2928-9882","observed_orcids":["https://orcid.org/0009-0006-2928-9882"]},"institutions":[{"id":"https://openalex.org/I2801798921","display_name":"Helmholtz-Zentrum Dresden-Rossendorf","ror":"https://ror.org/01zy2cs03","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I2801798921"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Subhadeep Paul","raw_affiliation_strings":["Helmholtz-Zentrum Dresden\u2014Rossendorf, Institute of Radiopharmaceutical Cancer Research, 01328 Dresden, Germany"],"raw_orcid":"https://orcid.org/0009-0006-2928-9882","affiliations":[{"raw_affiliation_string":"Helmholtz-Zentrum Dresden\u2014Rossendorf, Institute of Radiopharmaceutical Cancer Research, 01328 Dresden, Germany","institution_ids":["https://openalex.org/I2801798921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001927919","display_name":"Sven Stadlbauer","orcid":"https://orcid.org/0000-0003-2276-5330","observed_orcids":["https://orcid.org/0000-0003-2276-5330"]},"institutions":[{"id":"https://openalex.org/I2801798921","display_name":"Helmholtz-Zentrum Dresden-Rossendorf","ror":"https://ror.org/01zy2cs03","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I2801798921"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sven Stadlbauer","raw_affiliation_strings":["Helmholtz-Zentrum Dresden\u2014Rossendorf, Institute of Radiopharmaceutical Cancer Research, 01328 Dresden, Germany"],"raw_orcid":"https://orcid.org/0000-0003-2276-5330","affiliations":[{"raw_affiliation_string":"Helmholtz-Zentrum Dresden\u2014Rossendorf, Institute of Radiopharmaceutical Cancer Research, 01328 Dresden, Germany","institution_ids":["https://openalex.org/I2801798921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048070298","display_name":"Aleksandr Eismant","orcid":"https://orcid.org/0000-0002-9750-236X","observed_orcids":["https://orcid.org/0000-0002-9750-236X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aleksandr Eismant","raw_affiliation_strings":["Curanosticum MVZ GmbH Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, 65191 Wiesbaden, Germany"],"raw_orcid":"https://orcid.org/0000-0002-9750-236X","affiliations":[{"raw_affiliation_string":"Curanosticum MVZ GmbH Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, 65191 Wiesbaden, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160109982","display_name":"Rimos Lahdo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rimos Lahdo","raw_affiliation_strings":["Curanosticum MVZ GmbH Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, 65191 Wiesbaden, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Curanosticum MVZ GmbH Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, 65191 Wiesbaden, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044433416","display_name":"Christian Landvogt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christian Landvogt","raw_affiliation_strings":["Curanosticum MVZ GmbH Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, 65191 Wiesbaden, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Curanosticum MVZ GmbH Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, 65191 Wiesbaden, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051446048","display_name":"Richard Paul Baum","orcid":"https://orcid.org/0000-0003-1723-0075","observed_orcids":["https://orcid.org/0000-0003-1723-0075"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard P. Baum","raw_affiliation_strings":["Curanosticum MVZ GmbH Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, 65191 Wiesbaden, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Curanosticum MVZ GmbH Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, 65191 Wiesbaden, Germany","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065878136","display_name":"Lukas Greifenstein","orcid":"https://orcid.org/0000-0003-4040-8468","observed_orcids":["https://orcid.org/0000-0003-4040-8468"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Lukas Greifenstein","raw_affiliation_strings":["Curanosticum MVZ GmbH Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, 65191 Wiesbaden, Germany"],"raw_orcid":"https://orcid.org/0000-0003-4040-8468","affiliations":[{"raw_affiliation_string":"Curanosticum MVZ GmbH Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, 65191 Wiesbaden, Germany","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5044765728","https://openalex.org/A5065878136"],"corresponding_institution_ids":[],"apc_list":{"value":2900,"currency":"CHF","value_usd":3499},"apc_paid":{"value":2900,"currency":"CHF","value_usd":3499},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.84346389,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"19","issue":"11","first_page":"1707","last_page":"1707"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9800000190734863,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9800000190734863,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12505","display_name":"Peptidase Inhibition and Analysis","score":0.017999999225139618,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fibroblast-activation-protein","display_name":"fibroblast activation protein","score":0.9760000109672546},{"id":"https://openalex.org/keywords/fapi-04","display_name":"FAPI-04","score":0.8769999742507935},{"id":"https://openalex.org/keywords/gallium-68-radiolabeling","display_name":"gallium-68 radiolabeling","score":0.9079999923706055},{"id":"https://openalex.org/keywords/radiopharmaceutical-synthesis","display_name":"radiopharmaceutical synthesis","score":0.8529999852180481},{"id":"https://openalex.org/keywords/radiochemical-purity","display_name":"radiochemical purity","score":0.6150000095367432},{"id":"https://openalex.org/keywords/in-vitro-stability","display_name":"in vitro stability","score":0.7080000042915344},{"id":"https://openalex.org/keywords/tumor-imaging","display_name":"tumor imaging","score":0.6299999952316284},{"id":"https://openalex.org/keywords/radionuclide-therapy","display_name":"radionuclide therapy","score":0.8849999904632568}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.60589998960495},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5838000178337097},{"id":"https://openalex.org/C180577832","wikidata":"https://www.wikidata.org/wiki/Q127920","display_name":"Covalent bond","level":2,"score":0.4262999892234802},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.40470001101493835},{"id":"https://openalex.org/C3020018676","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Retention time","level":2,"score":0.3824999928474426},{"id":"https://openalex.org/C111798993","wikidata":"https://www.wikidata.org/wiki/Q21117471","display_name":"Fibroblast activation protein, alpha","level":3,"score":0.35010001063346863},{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.33390000462532043},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.33180001378059387},{"id":"https://openalex.org/C2988375501","wikidata":"https://www.wikidata.org/wiki/Q847556","display_name":"Protein stability","level":2,"score":0.2989000082015991},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.27880001068115234},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.27459999918937683},{"id":"https://openalex.org/C3020199158","wikidata":"https://www.wikidata.org/wiki/Q210521","display_name":"High resolution","level":2,"score":0.2694999873638153},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.2685000002384186},{"id":"https://openalex.org/C3017724952","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Pet imaging","level":3,"score":0.2612999975681305},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.260699987411499},{"id":"https://openalex.org/C136229726","wikidata":"https://www.wikidata.org/wiki/Q327092","display_name":"Biomedical engineering","level":1,"score":0.2538999915122986},{"id":"https://openalex.org/C198684833","wikidata":"https://www.wikidata.org/wiki/Q2823748","display_name":"Specific activity","level":3,"score":0.2538999915122986},{"id":"https://openalex.org/C148898269","wikidata":"https://www.wikidata.org/wiki/Q1108792","display_name":"Kinetics","level":2,"score":0.25209999084472656}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3390/ph19111707","doi":"https://doi.org/10.3390/ph19111707","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ph19111707","pdf_url":null,"source":{"id":"https://openalex.org/S16322639","display_name":"Pharmaceuticals","issn_l":"1424-8247","issn":["1424-8247"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3390/ph19111707","doi":"https://doi.org/10.3390/ph19111707","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ph19111707","pdf_url":null,"source":{"id":"https://openalex.org/S16322639","display_name":"Pharmaceuticals","issn_l":"1424-8247","issn":["1424-8247"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W2028506868","https://openalex.org/W2077759978","https://openalex.org/W2617914403","https://openalex.org/W2887241162","https://openalex.org/W2921110418","https://openalex.org/W2930582547","https://openalex.org/W2959958883","https://openalex.org/W3006838938","https://openalex.org/W3046645755","https://openalex.org/W3167796732","https://openalex.org/W3173129720","https://openalex.org/W3173923097","https://openalex.org/W3202195242","https://openalex.org/W3212453381","https://openalex.org/W3217498514","https://openalex.org/W4200229842","https://openalex.org/W4213023092","https://openalex.org/W4281254255","https://openalex.org/W4281400179","https://openalex.org/W4285388711","https://openalex.org/W4291512940","https://openalex.org/W4294276864","https://openalex.org/W4362594490","https://openalex.org/W4379335716","https://openalex.org/W4398201024","https://openalex.org/W4400688144","https://openalex.org/W4402477272","https://openalex.org/W4403872184","https://openalex.org/W4404865221","https://openalex.org/W7125365509","https://openalex.org/W7133195590"],"related_works":["https://openalex.org/W4388923612","https://openalex.org/W7160471765","https://openalex.org/W4413107845","https://openalex.org/W3166748100","https://openalex.org/W4362594490","https://openalex.org/W4405894432","https://openalex.org/W7204135353","https://openalex.org/W4416818987","https://openalex.org/W4410934980","https://openalex.org/W4353072285"],"abstract_inverted_index":{"Background/Objectives:":[0],"Fibroblast":[1],"activation":[2],"protein":[3],"(FAP)":[4],"represents":[5,198],"an":[6,33],"attractive":[7],"target":[8],"for":[9,73,121,131,137,140,143,202],"both":[10,122,179],"cancer":[11],"imaging":[12],"and":[13,68,88,100,134,165,181,186,208],"radionuclide":[14],"therapy.":[15],"Nevertheless,":[16],"the":[17,109,211],"prolonged":[18],"retention":[19,64,204],"of":[20,116,128,159,214],"many":[21],"FAP-targeting":[22],"inhibitors":[23],"within":[24],"tumor":[25,63],"tissue":[26],"remains":[27],"challenging.":[28],"Therefore,":[29],"we":[30],"investigated":[31],"FAPi-mFS,":[32],"FAP":[34,195],"inhibitor":[35],"derived":[36],"from":[37],"FAPi-04":[38],"that":[39],"carries":[40],"a":[41,54,193,199],"fluorosulfate":[42],"warhead":[43],"in":[44,101,153,206],"meta":[45],"position.":[46],"This":[47],"structural":[48],"feature":[49],"was":[50],"designed":[51],"to":[52,59,146],"enable":[53],"predominantly":[55],"irreversible":[56],"covalent":[57,194],"binding":[58],"FAP,":[60],"thereby":[61],"improving":[62],"time.":[65],"Methods:":[66],"[68Ga]Ga-FAPi-mFS":[67],"[177Lu]Lu-FAPi-mFS":[69],"were":[70,90,119],"successfully":[71],"synthesized":[72],"large-scale":[74],"clinical":[75],"use":[76],"by":[77],"radiolabeling":[78,110],"FAPi-mFS":[79,173,197],"under":[80],"validated":[81],"conditions.":[82],"The":[83],"radiochemical":[84,114],"conversion,":[85],"yield,":[86],"purity":[87,185],"stability":[89,105,155,187],"evaluated":[91],"using":[92,188],"radio-thin-layer":[93],"chromatography":[94,98],"(TLC),":[95],"radio-high-performance":[96],"liquid":[97],"(HPLC),":[99],"vitro":[102,154],"human":[103],"serum":[104],"tests.":[106],"Results:":[107],"In":[108],"experiments,":[111],"reproducibly":[112],"high":[113,152,184],"purities":[115],"over":[117,129,135,162,168],"96%":[118],"achieved":[120],"nuclides,":[123],"along":[124],"with":[125,156,178,183],"decay-corrected":[126],"yields":[127],"90%":[130],"gallium-68":[132],"(Ga-68)":[133],"80%":[136],"lutetium-177":[138],"(Lu-177)":[139],"batch":[141],"sizes":[142],"Lu-177":[144,166,182],"up":[145],"50":[147],"GBq.":[148],"Both":[149],"radiopharmaceuticals":[150],"exhibited":[151],"minimal":[157],"release":[158],"Ga-68":[160,180],"(<1%)":[161],"90":[163],"min":[164],"(<11%)":[167],"two":[169],"physical":[170],"half-lives.":[171],"Conclusions:":[172],"can":[174],"be":[175],"efficiently":[176],"labeled":[177],"clinically":[189],"applicable":[190],"procedures.":[191],"As":[192],"inhibitor,":[196],"promising":[200],"strategy":[201],"prolonging":[203],"time":[205],"tumors":[207],"potentially":[209],"enhancing":[210],"therapeutic":[212],"efficacy":[213],"FAP-specific":[215],"radiopharmaceuticals.":[216]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-30T00:00:00"}